Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Primary varicella zoster infection associated with fingolimod treatment.
Social support, depression, and physical disability: Age and diagnostic group effects.
Clostridia as agents of zoonotic disease.
Cerebral arterial and venous blood flow in adolescent multiple sclerosis patients and age-matched controls using phase contrast MRI.
Vitamin D: Health Panacea or false Prophet?
Predictors of disability worsening in clinically isolated syndrome.
Multiple sclerosis: managing a complex neurological disease.
Perceived changes and minimum clinically important difference of the Neurological Fatigue Index for multiple sclerosis (NFI-MS).
Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitors Remyelinate the Brain and Rescue Behavioral Deficits following Radiation.
Reproduction and the risk of multiple sclerosis.
2015 Multiple Sclerosis Experts Summit.
Higher burden of migraine compared to other neurological conditions: results from a cross-sectional study.
Relationships among physical inactivity, deconditioning, and walking impairment in persons with multiple sclerosis.
Alemtuzumab (LEMTRADA) and multiple sclerosis. Biased evaluation, evidence of serious risks.
Pharmacogenomics of interferon-β in multiple sclerosis: What has been accomplished and how can we ensure future progress?
Systemic treatment with the inhibitory neurotransmitter gamma-aminobutyric acid aggravates experimental autoimmune encephalomyelitis by affecting proinflammatory immune responses.
Responsibilities of Health Care Professionals in Counseling and Educating Patients With Incurable Neurological Diseases Regarding "Stem Cell Tourism": Caveat Emptor.
More than just multiple sclerosis.
Characterisation of uveitis in association with multiple sclerosis.
Natalizumab in the pediatric MS population: results of the Italian registry.
Glutathione in multiple sclerosis: More than just an antioxidant?
CD226 Gly307Ser association with multiple autoimmune diseases: A meta-analysis.
TNF-alpha Production by Peripheral Blood Monocytes in Multiple Sclerosis Patients and Healthy Controls.
Antigen Microarrays for the Study of Autoimmune Diseases.
Alemtuzumab treatment of multiple sclerosis.
Pages
« first
‹ previous
…
253
254
255
256
257
258
259
260
261
…
next ›
last »